汤文璐 - 复旦大学

个人简介

汤文璐，女，医学博士，硕士生导师。复旦大学副教授，药学院循证药物治疗课题组PI。 2003年毕业于复旦大学药学院临床药理专业，获医学博士学位。兼具临床医学和临床药理学两方面的教育和实践背景。2003-2005年在上海交通大学药学院任教。2006年加入复旦大学药学院药理教研室工作至今。在职期间作为复旦大学骨干教师两次赴加拿大英属哥伦比亚大学 (University of British Columbia, UBC)及循证药物治疗领域国际权威机构Cochrane Collaboration访学，目前是Cochrane Collaboration专业组中 Hypertension Group的研究成员。先后主持Cochrane Systematic Review、上海市科委自然科学基金项目、上海市卫生局面上项目及高校科研课题；作为主研承担国家自然科学基金、教育部博士点基金、上海市自然科学基金、上海市科委公共服务平台等项目。发表科研论文三十余篇（仅以第一兼/或通讯作者计），关于老年糖尿病药物流行病学研究的相关成果在该领域权威的国际药物流行病学会的会刊Pharmacoepidemiology& Drug Safety上多次发表论著；关于高血压的循证药物治疗证据在被ISI web of Knowledge收录包括《新英格兰杂志》在内的全科领域151 种期刊中排名第10的Cochrane Database of Systematic Reviews上成功发表。

研究领域

研究方向主要集中在临床药理学、循证药物治疗及药物流行病学。当前作为Cochrane Hypertension Group的研究成员，主要致力于研究制作临床药物治疗的最高级别证据— Cochrane系统评价，以期推动临床药理学和循证医学交叉的一门新兴前沿学科—循证药物治疗（Evidence-based pharmacotherapy ）在我国的顺利发展。目前在该新兴研究方向上已培养和正在指导硕士研究生及本科生近10人，课题组与Cochrane协作网的高血压系统评价组有长期科研合作关系。

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Chen YJ, Li LJ, Tang W*, Song JY, Qiu R, Li Q, Xue H, Wright JM. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension (Update). Cochrane Database of Systematic Reviews, 2018, in press. Wang GM, Chen YJ, Li LJ, Tang WL*. Comparative analysis of renin angiotensin system (RAS) inhibitors and other antihypertensive agents in hypertensive patients with type 2 Diabetes Mellitus (T2DM): a systematic review and meta-analysis. Journal of Human Hypertension, 2018, in press Li LJ, Chen YJ, Wang GM, Tang WL*, Wright JM. Renin inhibitors versus angiotensin receptor blockers for primary hypertension (Protocol). Cochrane Database of Systematic Reviews, 2017, Issue 2. Art. No.: CD012570.DOI: 10.1002/14651858.CD012570. Wang GM, Li LJ, Chen YJ, Tang WL*, Wright JM. Renin inhibitors versus angiotensin converting enzyme inhibitors for primary hypertension (Protocol). Cochrane Database of Systematic Reviews, 2017, Issue 2. Art. No.: CD012569.DOI: 10.1002/14651858.CD012569. Lu Z, Chen Y, Li L, Wang G, Xue H, Tang W*. Combination therapy of renin-angiotensin system inhibitors plus calcium channel blockers versus other two-drug combinations for hypertension: a systematic review and meta-analysis. Journal of Human Hypertension, 2017, 31(1): 1-13. Li LJ, Chen YJ, Tang WL*. Transformation of Teaching Assistants' Roles in Pharmaceutical Education Based on MOOC. Chinese Journal of Clinical Pharmacy, 2017, 26(6): 409-413. Tang WL. Exploration and practice of flipped classroom based on MOOC ‘antimicrobial and superbug’. Chinese Journal of Clinical Pharmacy, 2016, 25(4):247-250. Xue H, Lu Z, Tang WL*, Pang LW, Wang GM, Wong GWK, Wright JM. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension. Cochrane Database of Systematic Reviews, 2015, Issue 1. Art. No.: CD008170.pub2. DOI: 10.1002/14651858.CD008170.pub2. Tang WL. A new breakthrough in the reform of pharmacy teaching model based on MOOC. Chinese Journal of Clinical Pharmacy, 2015, 24(6): 378-380. Pang L.W., Wang G.M., Tang W.L.*, Lu Z, Chen Y.J. Antihypertensive agents utilization among inpatients in five hospitals in Shanghai in 2011. Chinese Journal of Clinical Pharmacy, 2014, 23(6):361-365. Tang WL*, Mao YC, Hong L. The Significance of Basic Medical Education for Pharmacy Students. Chinese Journal of Clinical Pharmacy, 2014, 23(4):256-258. Tang W, He M, Yang B, Wei K, Yin M, Zhang L*. Association study of polymorphisms in the cyclooxygenase-2 gene and Alzheimer’s disease risk in Chinese. Neurological Sciences, 2013, 34 (5):695-699. Zhao D, Tang W.L.*, Wang F. Analysis of influencing factors on observed regional difference in treatment effects in clinical trial. Chinese Journal of New Drugs and Clinical Remedies, 2013, 32 (11):876-879. Yang P, Chen X.W., Tang W.L.*, Xue H, Lu Z. Oral hypoglycemic agents utilization among inpatients in five hospitals in Shanghai from 2007 to 2011. Chinese Journal of Clinical Pharmacy, 2013, 22(6):345-350.